SCHEDULE 13G

REVANCE THERAPEUTICS INC

Common Stock · CUSIP: 761330109

Event date: 2025-01-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Beryl Capital Management LLC

  Shares: 6,359,570.00 · Class: 6.1%

• Beryl Capital Management LP

  Shares: 6,359,570.00 · Class: 6.1%

• Beryl Capital Partners II LP

  Shares: 5,589,328.00 · Class: 5.3%

• David A. Witkin

  Shares: 6,359,570.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.